A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Alefacept (Primary) ; Alefacept (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- 18 Nov 2011 Planned end date changed from 1 Dec 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 18 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 28 Apr 2011 Planned End Date changed from 1 Jun 2011 to 1 Dec 2011.